Cytarabine Dose for Acute Myeloid Leukemia

Bob Lowenberg, Thomas Pabst, Edo Vellenga, Wim van Putten, Harry C. Schouten, Carlos Graux, Augustin Ferrant, Pieter Sonneveld, Bart J. Biemond, Alois Gratwohl, Georgine E. de Greef, Leo F. Verdonck, Martijn R. Schaafsma, Michael Gregor, Matthias Theobald, Urs Schanz, Johan Maertens, Gert Jan Ossenkoppele

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1027-1036
JournalNew England Journal of Medicine
Volume364
Issue number11
DOIs
Publication statusPublished - 17 Mar 2011

Cite this

Lowenberg, B., Pabst, T., Vellenga, E., van Putten, W., Schouten, H. C., Graux, C., Ferrant, A., Sonneveld, P., Biemond, B. J., Gratwohl, A., de Greef, G. E., Verdonck, L. F., Schaafsma, M. R., Gregor, M., Theobald, M., Schanz, U., Maertens, J., & Ossenkoppele, G. J. (2011). Cytarabine Dose for Acute Myeloid Leukemia. New England Journal of Medicine, 364(11), 1027-1036. https://doi.org/10.1056/NEJMoa1010222